{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:53:32Z","timestamp":1793404412257,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":131,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.curtheres.2025.100798","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T18:36:35Z","timestamp":1748370995000},"page":"100798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cognitive Effect of Levetiracetam in Patients with Alzheimer\u2019s Disease or Mild Cognitive Impairment: A Systematic Review"],"prefix":"10.1016","volume":"103","author":[{"given":"Mohamad Hosein","family":"Mohamadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bavafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Abedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Jafarlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirhossein","family":"Kolivand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Sahab-Negah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2025.100798_bib0001","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/psyg.12484","article-title":"Early detection of cognitive disturbances in mild cognitive impairment: a systematic review of observational studies","volume":"20","author":"Chehrehnegar","year":"2020","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.curtheres.2025.100798_bib0002","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s44159-023-00149-0","article-title":"The roles of attention, executive function and knowledge in cognitive ageing of working memory","volume":"2","author":"Naveh-Benjamin","year":"2023","journal-title":"Nat Rev Psychol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/748212","article-title":"Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"2015","author":"Kirova","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.curtheres.2025.100798_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112904","article-title":"A systematic review of cognitive event-related potentials in mild cognitive impairment and Alzheimer\u2019s disease","volume":"396","author":"Paitel","year":"2021","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.curtheres.2025.100798_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2022.104030","article-title":"Applications of artificial intelligence to aid early detection of dementia: a scoping review on current capabilities and future directions","volume":"127","author":"Li","year":"2022","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.curtheres.2025.100798_bib0006","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/fcp.12861","article-title":"Molecular mechanisms of Alzheimer\u2019s disease: from therapeutic targets to promising drugs","volume":"37","author":"Alan","year":"2023","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0007","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0009","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s12031-020-01555-2","article-title":"Neuronal plasticity: neuronal organization is associated with neurological disorders","volume":"70","author":"Dhuriya","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.837649","article-title":"Multi-targets: an unconventional drug development strategy for Alzheimer\u2019s disease","volume":"14","author":"Gong","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0011","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.curtheres.2025.100798_bib0012","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.curtheres.2025.100798_bib0013","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/jcp.29908","article-title":"MicroRNA alterations in neuropathologic cognitive disorders with an emphasis on dementia: lessons from animal models","volume":"236","author":"Bahlakeh","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.curtheres.2025.100798_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.888784","article-title":"Levetiracetam alleviates cognitive decline in Alzheimer\u2019s disease animal model by ameliorating the dysfunction of the neuronal network","volume":"14","author":"Zheng","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnbeh.2019.00048","article-title":"Potentials and pitfalls of cross-translational models of cognitive impairment","volume":"13","author":"Al Dahhan","year":"2019","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0017","article-title":"The HOPE4MCI study: a randomized double-blind assessment of AGB101 for the treatment of MCI due to AD","volume":"10","author":"Mohs","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.curtheres.2025.100798_bib0018","first-page":"121","article-title":"Considerations for the safe use of levetiracetam, generic type of the antiepileptic drug","volume":"103","author":"Tiamkao","year":"2020","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.curtheres.2025.100798_bib0019","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneurol.2014.181","article-title":"Classifying neurocognitive disorders: the DSM-5 approach","volume":"10","author":"Sachdev","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0020","series-title":"Encyclopedia of Clinical Neuropsychology","first-page":"1079","article-title":"Free recall","author":"Haberlandt","year":"2011"},{"key":"10.1016\/j.curtheres.2025.100798_bib0021","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1073191115602552","article-title":"The trail making test","volume":"24","author":"Llin\u00e0s-Regl\u00e0","year":"2017","journal-title":"Assessment"},{"key":"10.1016\/j.curtheres.2025.100798_bib0022","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/arclin\/acae022","article-title":"Utility of a short-form phonemic fluency task","volume":"39","author":"Kaufman","year":"2024","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0023","first-page":"288","article-title":"Preliminary normative data of Persian phonemic and semantic verbal fluency test","volume":"13","author":"Ghasemian-Shirvan","year":"2018","journal-title":"Iran J Psychiatry"},{"key":"10.1016\/j.curtheres.2025.100798_bib0024","doi-asserted-by":"crossref","first-page":"P154","DOI":"10.1093\/geronj\/47.3.P154","article-title":"Boston naming test: shortened versions for use in Alzheimer's disease","volume":"47","author":"Mack","year":"1992","journal-title":"J Gerontol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nrleng.2018.12.019","article-title":"Preliminary analysis of a shortened picture version of the free and cued selective reminding test","volume":"37","author":"Rodrigo-Herrero","year":"2022","journal-title":"Neurolog\u00eda (Engl Ed)"},{"key":"10.1016\/j.curtheres.2025.100798_bib0026","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/sjop.12470","article-title":"Psychometric properties and reference data for Danish versions of free and cued selective reminding test, category cued memory test and logical memory","volume":"59","author":"Vogel","year":"2018","journal-title":"Scand J Psychol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0027","series-title":"Cognitive Screening Instruments: A Practical Approach","first-page":"79","article-title":"Clock drawing test","author":"Mainland","year":"2012"},{"key":"10.1016\/j.curtheres.2025.100798_bib0028","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000203344","article-title":"Literature review of the clock drawing test as a tool for cognitive screening","volume":"27","author":"Pinto","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.curtheres.2025.100798_bib0029","series-title":"Principles and Practice of Geriatric Psychiatry","first-page":"140","article-title":"Mini-mental state examination","author":"Cockrell","year":"2002"},{"key":"10.1016\/j.curtheres.2025.100798_bib0030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2318-10-36","article-title":"The factorial structure of the Mini-Mental State Examination (MMSE) in Japanese dementia patients","volume":"10","author":"Shigemori","year":"2010","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.curtheres.2025.100798_bib0031","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI)","volume":"2015","author":"Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.curtheres.2025.100798_bib0032","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): modifications and responsiveness in pre-dementia populations. A narrative review","volume":"63","author":"Kueper","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.curtheres.2025.100798_bib0033","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S1355617713001094","article-title":"NIH EXAMINER: conceptualization and development of an executive function battery","volume":"20","author":"Kramer","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.curtheres.2025.100798_bib0034","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fpsyg.2017.00557","article-title":"The stroop color and word test","volume":"8","author":"Scarpina","year":"2017","journal-title":"Front Psychol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1533317508325095","article-title":"Levetiracetam: a practical option for seizure management in elderly patients with cognitive impairment","volume":"25","author":"Lippa","year":"2010","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.curtheres.2025.100798_bib0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.curtheres.2025.100798_bib0037","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam alters oscillatory connectivity in Alzheimer\u2019s disease","volume":"58","author":"Musaeus","year":"2017","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.curtheres.2025.100798_bib0038","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0039","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","article-title":"Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment","volume":"74","author":"Bakker","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.curtheres.2025.100798_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.job.2023.11.006","article-title":"Biological profiling using the human mandible","volume":"66","author":"Abualhija","year":"2024","journal-title":"J Oral Biosci"},{"key":"10.1016\/j.curtheres.2025.100798_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22037-y","article-title":"Prevalence and characteristics of dry eye disease in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"12","author":"Nagino","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.curtheres.2025.100798_bib0042","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12891-019-2619-8","article-title":"Preoperative opioid use is associated with worse patient outcomes after total joint arthroplasty: a systematic review and meta-analysis","volume":"20","author":"Goplen","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.curtheres.2025.100798_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2038","article-title":"Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy","volume":"11","author":"Ogunjimi","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.curtheres.2025.100798_bib0044","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yebeh.2008.07.012","article-title":"The effects of levetiracetam on cognition: a non-interventional surveillance study","volume":"13","author":"Helmstaedter","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.curtheres.2025.100798_bib0045","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/epi.13849","article-title":"A randomized, double-blind, placebo-controlled crossover study of the effects of levetiracetam on cognition, mood, and balance in healthy older adults","volume":"58","author":"Schoenberg","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2025.100798_bib0046","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1678581","article-title":"Current and future treatments in Alzheimer\u2019s disease","volume":"39","author":"Atri","year":"2019","journal-title":"Semin Neurol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0047","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1001\/jama.2014.13806","article-title":"The diagnosis and management of mild cognitive impairment: a clinical review","volume":"312","author":"Langa","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.curtheres.2025.100798_bib0048","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11011-021-00888-0","article-title":"Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer\u2019s disease","volume":"37","author":"Alavi","year":"2022","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.curtheres.2025.100798_bib0049","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuroscience.2019.07.015","article-title":"Protective role of levetiracetam against cognitive impairment and brain white matter damage in mouse prolonged cerebral hypoperfusion","volume":"414","author":"Inaba","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.curtheres.2025.100798_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1134\/S2079057018010137","article-title":"Age-related dynamics of cognitive functions in persons aged 50\u201385 years","volume":"8","author":"Zakharov","year":"2018","journal-title":"Adv Gerontol"},{"key":"10.1016\/j.curtheres.2025.100798_bib0051","first-page":"649","article-title":"An overview of the rare and life-threatening adverse effects of levetiracetam","volume":"9","author":"Nizamudeen","year":"2020","journal-title":"World J Pharm Res"},{"key":"10.1016\/j.curtheres.2025.100798_bib0052","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00296-0","article-title":"A systematic review of the safety profile of levetiracetam: a new antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.curtheres.2025.100798_bib0053","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/epi.17228","article-title":"A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam","volume":"63","author":"Campbell","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2025.100798_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108493","article-title":"Differences in aggression as psychiatric side effect of levetiracetam and perampanel in patients with epilepsy","volume":"126","author":"Kawai","year":"2022","journal-title":"Epilepsy Behav"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X25000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X25000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:13:06Z","timestamp":1765357986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X25000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":54,"alternative-id":["S0011393X25000232"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2025.100798","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive Effect of Levetiracetam in Patients with Alzheimer\u2019s Disease or Mild Cognitive Impairment: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2025.100798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100798"}}